home / stock / kura / kura short
Short Information | Kura Oncology Inc. (NASDAQ:KURA)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 3,201,850 |
Total Actual Volume | 17,050,628 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 160,093 |
Average Short Percentage | 17.84% |
Is there a KURA Short Squeeze or Breakout about to happen?
See the KURA Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-24-2024 | $18.75 | $18.75 | $18.92 | $18.41 | 665,435 | 81,575 | 12.26% |
04-23-2024 | $18.12 | $18.73 | $19.27 | $18.12 | 1,038,202 | 235,005 | 22.64% |
04-22-2024 | $18.33 | $18.19 | $19.18 | $17.92 | 2,099,668 | 360,976 | 17.19% |
04-19-2024 | $17.61 | $17.53 | $17.9 | $16.79 | 1,329,668 | 380,322 | 28.6% |
04-18-2024 | $17.86 | $17.68 | $18.05 | $17.52 | 1,653,399 | 478,497 | 28.94% |
04-17-2024 | $18.8 | $17.99 | $18.89 | $17.89 | 660,270 | 103,219 | 15.63% |
04-16-2024 | $18.81 | $18.59 | $18.945 | $18.41 | 821,071 | 143,076 | 17.43% |
04-15-2024 | $19.57 | $19.01 | $19.7 | $18.59 | 751,803 | 79,085 | 10.52% |
04-12-2024 | $20.3 | $19.48 | $20.3 | $19 | 637,108 | 110,847 | 17.4% |
04-11-2024 | $20.04 | $20.4 | $20.62 | $20.04 | 764,312 | 143,080 | 18.72% |
04-10-2024 | $20.07 | $19.9 | $20.24 | $19.7 | 869,070 | 136,213 | 15.67% |
04-09-2024 | $20.44 | $20.68 | $20.81 | $20 | 404,859 | 80,304 | 19.84% |
04-08-2024 | $20.65 | $20.42 | $20.76 | $20.12 | 304,440 | 70,117 | 23.03% |
04-05-2024 | $20.09 | $20.36 | $20.81 | $19.58 | 599,650 | 73,300 | 12.22% |
04-04-2024 | $20.58 | $20.36 | $21.38 | $20.2 | 918,005 | 174,318 | 18.99% |
04-03-2024 | $20.29 | $20.34 | $20.826 | $20.23 | 553,569 | 64,452 | 11.64% |
04-02-2024 | $21.3 | $20.52 | $21.3 | $20.27 | 752,861 | 140,004 | 18.6% |
04-01-2024 | $21.19 | $21.82 | $21.89 | $20.975 | 705,380 | 158,503 | 22.47% |
03-28-2024 | $21.17 | $21.33 | $21.645 | $20.89 | 867,490 | 102,320 | 11.79% |
03-27-2024 | $20.44 | $21.17 | $21.23 | $20.265 | 654,368 | 86,637 | 13.24% |
News, Short Squeeze, Breakout and More Instantly...
– Ziftomenib is the first investigational treatment to be granted Breakthrough Therapy Designation for NPM1-mutant AML – – Registration-directed trial of ziftomenib in NPM1-mutant AML on track to complete enrollment by mid-2024 – SAN DIEGO, April 22, 2024 (GLOB...
SAN DIEGO, April 10, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ:KURA), a clinical-stage biopharmaceutical company committed to realizi...
SAN DIEGO, April 10, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced its participation in Stifel 2024 Targeted Oncology Forum. Troy Wilson...